CD8A and infection: mRNA, Novavax and adenovirus‐based SARS‐CoV‐2 vaccines induce spike‐specific CD4+ and CD8+ T cells in most individuals 6 months after the first dose. mRNA and Novavax vaccines induce a greater magnitude of spike‐specific CD4+ T cells than natural infection